Expanded alliance advances cancer immunology pipeline | Press
[unable to retrieve full-text content]
The collaboration for the discovery of novel selective tumor targets for Boehringer Ingelheim's unique T-cell engager, cancer vaccine and oncolytic v.
Published at Wed, 14 Oct 2020 16:34:42 +0000